Cargando…
Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease
Patients with chronic inflammatory diseases (CID) experience accelerated loss of bone mineral density, which is often accompanied by increased vascular calcification. These disturbances can be attenuated by therapies for inflammation, such as the tumor necrosis factor inhibitor infliximab. Calciprot...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216135/ https://www.ncbi.nlm.nih.gov/pubmed/34189386 http://dx.doi.org/10.1002/jbm4.10497 |